NEXT Financial Group, Inc - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 138 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$6,000
-99.4%
2,000
+300.0%
0.00%
Q4 2016$1,000,000
+99900.0%
5000.0%0.00%
Q3 2016$1,000
-50.0%
500
+150.0%
0.00%
-100.0%
Q1 2015$2,000
-33.3%
2000.0%0.00%0.0%
Q4 2014$3,000
-62.5%
200
-66.7%
0.00%
-50.0%
Q3 2014$8,0006000.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
BVF INC/IL 7,866,108$25,408,0004.32%
Nine Chapters Capital Management LLC 91,500$296,0000.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,969,225$6,361,0000.24%
Orbimed Advisors 3,250,300$10,498,0000.12%
PINNACLE ASSOCIATES LTD 1,306,679$4,221,0000.08%
PLATINUM INVESTMENT MANAGEMENT LTD 810,232$2,617,0000.07%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 270,417$873,0000.06%
Rock Springs Capital Management LP 270,000$872,0000.05%
ALGERT GLOBAL LLC 39,876$129,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 391,671$1,265,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders